SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-03-000214
Filing Date
2003-02-10
Accepted
2003-02-10 11:33:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 d383215_13-g.txt SC 13G 19047
  Complete submission text file 0000919574-03-000214.txt   20760
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Subject) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-46794 | Film No.: 03546307
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
DEERFIELD CAPITAL LP ET AL (Filed by) CIK: 0001010823 (see all company filings)